University of Sao Paulo: Retinal Diseases trials
The registry lists 13 Retinal Diseases studies with University of Sao Paulo as lead sponsor. 0 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 10Phase 3 1Phase 4 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Pain During Pars Plana Vitrectomy With Sub-tenon AnesthesiaCompletedNCT03902925Phase 1/2
- PASCAL Laser Versus ETDRS Laser Associated With Intravitreal Ranibizumab (IVR) Versus Only IVR for Proliferative Diabetic RetinopathyStatus unknownNCT02005432Phase 4
- Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic RetinopathyCompletedNCT01746563Phase 1/2
- Effect of Intravitreal Bone Marrow Stem Cells on Ischemic RetinopathyStatus unknownNCT01518842Not applicable
- Bevacizumab Versus Ranibizumab for the Treatment of Diabetic Macular EdemaStatus unknownNCT01487629Phase 2
- Ranibizumab for Diabetic Traction Retinal DetachmentCompletedNCT01201161Phase 2
- Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic RetinopathyCompletedNCT01102946Phase 2
- Cpap at Delivery Room for Preterm InfantsStatus unknownNCT01024361Phase 4
- Intravitreal Ranibizumab For Persistent New Vessels In Diabetic Retinopathy(Inipe Study)Status unknownNCT00993525Phase 1/2
- Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabCompletedNCT00804921Phase 2
- Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA)CompletedNCT00690768Phase 2
- Preoperative Bevacizumab for Vitreous HemorrhageCompletedNCT00596297Phase 1/2
- Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic RetinopathyCompletedNCT00443521Phase 2/3